胰腺上皮内瘤变
CDKN2A
胰腺
癌症研究
胰腺癌
克拉斯
胰管
间质细胞
生物
病理
医学
癌症
基因
突变
内分泌学
遗传学
作者
Jonghyeob Lee,Emily R. Snyder,Yinghua Liu,Xueying Gu,Jing Wang,Brittany M. Flowers,Yoo Jung Kim,Sangbin Park,Gregory L. Szot,Ralph H. Hruban,Teri A. Longacre,Seung K. Kim
摘要
Abstract Development of systems that reconstitute hallmark features of human pancreatic intraepithelial neoplasia (PanINs), the precursor to pancreatic ductal adenocarcinoma, could generate new strategies for early diagnosis and intervention. However, human cell-based PanIN models with defined mutations are unavailable. Here, we report that genetic modification of primary human pancreatic cells leads to development of lesions resembling native human PanINs. Primary human pancreas duct cells harbouring oncogenic KRAS and induced mutations in CDKN2A , SMAD4 and TP53 expand in vitro as epithelial spheres. After pancreatic transplantation, mutant clones form lesions histologically similar to native PanINs, including prominent stromal responses. Gene expression profiling reveals molecular similarities of mutant clones with native PanINs, and identifies potential PanIN biomarker candidates including Neuromedin U, a circulating peptide hormone. Prospective reconstitution of human PanIN development from primary cells provides experimental opportunities to investigate pancreas cancer development, progression and early-stage detection.
科研通智能强力驱动
Strongly Powered by AbleSci AI